Hepatitis E vaccine shows promising 10-year efficacy in the Chinese population

1. Overall vaccine efficacy ranged from 83.1% to 86.6% during the 10-year period. 2. Detectable concentrations of antibodies persisted at the 8.5-year mark in Qindong. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis worldwide. Currently, two recombinant HEV vaccines exist; however, little is known

Related Keywords

Qindong ,Gansu ,China ,Dongtai ,Jiangsu ,Chinese , ,Rating Level ,Between Aug ,Dongtai County ,Gastroenterology ,Hepatitis ,Hepatitis E ,Hepatitise Vaccine ,Hepatitise Virus Hev ,Liver ,Chronic Disease ,Infectious Disease ,